Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 247

1.

Experimental Evaluation of UWB Indoor Positioning for Indoor Track Cycling.

Minne K, Macoir N, Rossey J, Brande QVD, Lemey S, Hoebeke J, Poorter E.

Sensors (Basel). 2019 May 1;19(9). pii: E2041. doi: 10.3390/s19092041.

2.

A Survey of LoRaWAN for IoT: From Technology to Application.

Haxhibeqiri J, De Poorter E, Moerman I, Hoebeke J.

Sensors (Basel). 2018 Nov 16;18(11). pii: E3995. doi: 10.3390/s18113995. Review.

3.

The Bluetooth Mesh Standard: An Overview and Experimental Evaluation.

Baert M, Rossey J, Shahid A, Hoebeke J.

Sensors (Basel). 2018 Jul 25;18(8). pii: E2409. doi: 10.3390/s18082409.

4.

Light-Weight Integration and Interoperation of Localization Systems in IoT.

Karaagac A, Suanet P, Joseph W, Moerman I, Hoebeke J.

Sensors (Basel). 2018 Jul 3;18(7). pii: E2142. doi: 10.3390/s18072142.

5.

Appdaptivity: An Internet of Things Device-Decoupled System for Portable Applications in Changing Contexts.

Martín C, Hoebeke J, Rossey J, Díaz M, Rubio B, Van den Abeele F.

Sensors (Basel). 2018 Apr 26;18(5). pii: E1345. doi: 10.3390/s18051345.

6.

Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma.

Jünemann A, Hohberger B, Rech J, Sheriff A, Fu Q, Schlötzer-Schrehardt U, Voll RE, Bartel S, Kalbacher H, Hoebeke J, Rejdak R, Horn F, Wallukat G, Kunze R, Herrmann M.

Front Immunol. 2018 Feb 12;9:145. doi: 10.3389/fimmu.2018.00145. eCollection 2018.

7.

Performance Evaluation of IEEE 802.11ah Networks With High-Throughput Bidirectional Traffic.

Šljivo A, Kerkhove D, Tian L, Famaey J, Munteanu A, Moerman I, Hoebeke J, De Poorter E.

Sensors (Basel). 2018 Jan 23;18(2). pii: E325. doi: 10.3390/s18020325.

8.

Experimental Evaluation of UWB Indoor Positioning for Sport Postures.

Ridolfi M, Vandermeeren S, Defraye J, Steendam H, Gerlo J, De Clercq D, Hoebeke J, De Poorter E.

Sensors (Basel). 2018 Jan 9;18(1). pii: E168. doi: 10.3390/s18010168.

9.

Secure Service Proxy: A CoAP(s) Intermediary for a Securer and Smarter Web of Things.

Van den Abeele F, Moerman I, Demeester P, Hoebeke J.

Sensors (Basel). 2017 Jul 11;17(7). pii: E1609. doi: 10.3390/s17071609.

10.

LoRa Scalability: A Simulation Model Based on Interference Measurements.

Haxhibeqiri J, Van den Abeele F, Moerman I, Hoebeke J.

Sensors (Basel). 2017 May 23;17(6). pii: E1193. doi: 10.3390/s17061193.

11.

Bindings and RESTlets: A Novel Set of CoAP-Based Application Enablers to Build IoT Applications.

Teklemariam GK, Van Den Abeele F, Moerman I, Demeester P, Hoebeke J.

Sensors (Basel). 2016 Aug 2;16(8). pii: E1217. doi: 10.3390/s16081217.

12.

Experimental Evaluation of Unicast and Multicast CoAP Group Communication.

Ishaq I, Hoebeke J, Moerman I, Demeester P.

Sensors (Basel). 2016 Jul 21;16(7). pii: E1137. doi: 10.3390/s16071137.

13.

A Review of Tools to Assist Hospitals in Meeting Community Health Assessment and Implementation Strategy Requirements.

Schifferdecker KE, Bazos DA, Sutherland KA, Ayers LaFave LR, Ruggles L, Fedrizzi R, Hoebeke J.

J Healthc Manag. 2016 Jan-Feb;61(1):44-56. Review.

14.

Towards a social and context-aware multi-sensor fall detection and risk assessment platform.

De Backere F, Ongenae F, Van den Abeele F, Nelis J, Bonte P, Clement E, Philpott M, Hoebeke J, Verstichel S, Ackaert A, De Turck F.

Comput Biol Med. 2015 Sep;64:307-20. doi: 10.1016/j.compbiomed.2014.12.002. Epub 2014 Dec 10.

PMID:
25542073
15.

The OCareCloudS project: Toward organizing care through trusted cloud services.

De Backere F, Ongenae F, Vannieuwenborg F, Van Ooteghem J, Duysburgh P, Jansen A, Hoebeke J, Wuyts K, Rossey J, Van den Abeele F, Willems K, Decancq J, Annema JH, Sulmon N, Van Landuyt D, Verstichel S, Crombez P, Ackaert A, De Grooff D, Jacobs A, De Turck F.

Inform Health Soc Care. 2016;41(2):159-76. doi: 10.3109/17538157.2014.965306. Epub 2014 Oct 17.

PMID:
25325572
16.

Flexible unicast-based group communication for CoAP-enabled devices.

Ishaq I, Hoebeke J, Van den Abeele F, Rossey J, Moerman I, Demeester P.

Sensors (Basel). 2014 Jun 4;14(6):9833-77. doi: 10.3390/s140609833.

17.

Action-learning collaboratives as a platform for community-based participatory research to advance obesity prevention.

Bazos DA, Schifferdecker KE, Fedrizzi R, Hoebeke J, Ruggles L, Goldsberry Y.

J Health Care Poor Underserved. 2013;24(2 Suppl):61-79. doi: 10.1353/hpu.2013.0104.

PMID:
23727965
18.

Selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β protein.

Ayub MJ, Nyambega B, Simonetti L, Duffy T, Longhi SA, Gómez KA, Hoebeke J, Levin MJ, Smulski CR.

PLoS One. 2012;7(5):e36233. doi: 10.1371/journal.pone.0036233. Epub 2012 May 3.

19.

Anti-β-adrenoceptors autoimmunity causing 'idiopathic' arrhythmias and cardiomyopathy.

Brisinda D, Sorbo AR, Venuti A, Ruggieri MP, Manna R, Fenici P, Wallukat G, Hoebeke J, Frustaci A, Fenici R.

Circ J. 2012;76(6):1345-53. Epub 2012 Mar 22.

20.

Reciprocal repression between P53 and TCTP.

Amson R, Pece S, Lespagnol A, Vyas R, Mazzarol G, Tosoni D, Colaluca I, Viale G, Rodrigues-Ferreira S, Wynendaele J, Chaloin O, Hoebeke J, Marine JC, Di Fiore PP, Telerman A.

Nat Med. 2011 Dec 11;18(1):91-9. doi: 10.1038/nm.2546.

PMID:
22157679
21.

Crystal structure of the complex mAb 17.2 and the C-terminal region of Trypanosoma cruzi P2β protein: implications in cross-reactivity.

Pizarro JC, Boulot G, Bentley GA, Gómez KA, Hoebeke J, Hontebeyrie M, Levin MJ, Smulski CR.

PLoS Negl Trop Dis. 2011 Nov;5(11):e1375. doi: 10.1371/journal.pntd.0001375. Epub 2011 Nov 1.

22.

Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor.

Chauvier D, Renolleau S, Holifanjaniaina S, Ankri S, Bezault M, Schwendimann L, Rousset C, Casimir R, Hoebeke J, Smirnova M, Debret G, Trichet AP, Carlsson Y, Wang X, Bernard E, Hébert M, Rauzier JM, Matecki S, Lacampagne A, Rustin P, Mariani J, Hagberg H, Gressens P, Charriaut-Marlangue C, Jacotot E.

Cell Death Dis. 2011 Sep 1;2:e203. doi: 10.1038/cddis.2011.87.

23.

Interaction map of the Trypanosoma cruzi ribosomal P protein complex (stalk) and the elongation factor 2.

Smulski CR, Longhi SA, Ayub MJ, Edreira MM, Simonetti L, Gómez KA, Basile JN, Chaloin O, Hoebeke J, Levin MJ.

J Mol Recognit. 2011 Mar-Apr;24(2):359-70. doi: 10.1002/jmr.1089. Epub 2010 Dec 13.

PMID:
21360618
24.

Direct visualization of peptide/MHC complexes at the surface and in the intracellular compartments of cells infected in vivo by Leishmania major.

Muraille E, Gounon P, Cazareth J, Hoebeke J, Lippuner C, Davalos-Misslitz A, Aebischer T, Muller S, Glaichenhaus N, Mougneau E.

PLoS Pathog. 2010 Oct 14;6(10):e1001154. doi: 10.1371/journal.ppat.1001154.

25.

Mechanisms of genetically-based resistance to malaria.

López C, Saravia C, Gomez A, Hoebeke J, Patarroyo MA.

Gene. 2010 Nov 1;467(1-2):1-12. doi: 10.1016/j.gene.2010.07.008. Epub 2010 Jul 22. Review.

PMID:
20655368
26.
27.

Rationally-designed multivalent architectures for mimicking homotrimers of CD40L, a member of the TNF superfamily.

Guichard G, Trouche N, Wieckowski S, Sun W, Chaloin O, Bianco A, Hoebeke J, Schneider P, Fournel S.

Adv Exp Med Biol. 2009;611:355-7. No abstract available.

PMID:
19400224
28.

Immunomodulatory consequences of ODN CpG-polycation complexes.

Partidos CD, Hoebeke J, Wieckowski S, Chaloin O, Bianco A, Moreau E, Briand JP, Desgranges C, Muller S.

Methods. 2009 Dec;49(4):328-33. doi: 10.1016/j.ymeth.2009.03.005. Epub 2009 Mar 18. Review.

PMID:
19303048
29.

Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease.

Levin MJ, Hoebeke J.

Autoimmunity. 2008 Sep;41(6):429-33. doi: 10.1080/08916930802031702. Review.

PMID:
18781468
30.

Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry.

Kabbage M, Chahed K, Hamrita B, Guillier CL, Trimeche M, Remadi S, Hoebeke J, Chouchane L.

J Biomed Biotechnol. 2008;2008:564127. doi: 10.1155/2008/564127.

31.

Small multivalent architectures mimicking homotrimers of the TNF superfamily member CD40L: delineating the relationship between structure and effector function.

Trouche N, Wieckowski S, Sun W, Chaloin O, Hoebeke J, Fournel S, Guichard G.

J Am Chem Soc. 2007 Nov 7;129(44):13480-92. Epub 2007 Oct 13.

PMID:
17935324
32.

Antibodies induced by Plasmodium falciparum merozoite surface antigen-2-designed pseudopeptides possess neutralizing properties of the in vitro malarial infection.

Lozano JM, Montoya-Fajardo FJ, Hoebeke J, Cifuentes GH, Forero M, Patarroyo ME.

Peptides. 2007 Oct;28(10):1954-65. Epub 2007 Aug 11.

PMID:
17881088
33.

Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivo.

Peter JC, Nicholson JR, Heydet D, Lecourt AC, Hoebeke J, Hofbauer KG.

Am J Physiol Regul Integr Comp Physiol. 2007 Jun;292(6):R2151-8. Epub 2007 Feb 22.

34.

Cooperativity in the interaction of synthetic CD40L mimetics with CD40 and its implication in cell signaling.

Wieckowski S, Trouche N, Chaloin O, Guichard G, Fournel S, Hoebeke J.

Biochemistry. 2007 Mar 20;46(11):3482-93. Epub 2007 Feb 24.

PMID:
17319699
35.

Heteroclitic properties of mixed alpha- and aza-beta3-peptides mimicking a supradominant CD4 T cell epitope presented by nucleosome.

Dali H, Busnel O, Hoebeke J, Bi L, Decker P, Briand JP, Baudy-Floc'h M, Muller S.

Mol Immunol. 2007 Apr;44(11):3024-36. Epub 2007 Feb 9.

PMID:
17292472
36.

Peptido-targeting of the mitochondrial transition pore complex for therapeutic apoptosis induction.

Deniaud A, Hoebeke J, Briand JP, Muller S, Jacotot E, Brenner C.

Curr Pharm Des. 2006;12(34):4501-11. Review.

PMID:
17168756
37.

Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation.

Racape J, Connan F, Hoebeke J, Choppin J, Guillet JG.

Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18208-13. Epub 2006 Nov 20.

38.

Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells.

Borgne-Sanchez A, Dupont S, Langonné A, Baux L, Lecoeur H, Chauvier D, Lassalle M, Déas O, Brière JJ, Brabant M, Roux P, Péchoux C, Briand JP, Hoebeke J, Deniaud A, Brenner C, Rustin P, Edelman L, Rebouillat D, Jacotot E.

Cell Death Differ. 2007 Mar;14(3):422-35. Epub 2006 Aug 4.

39.

Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.

Lacroix-Desmazes S, Wootla B, Dasgupta S, Delignat S, Bayry J, Reinbolt J, Hoebeke J, Saenko E, Kazatchkine MD, Friboulet A, Christophe O, Nagaraja V, Kaveri SV.

J Immunol. 2006 Jul 15;177(2):1355-63.

40.

Structural basis of the cross-reaction between an antibody to the Trypanosoma cruzi ribosomal P2beta protein and the human beta1 adrenergic receptor.

Smulski C, Labovsky V, Levy G, Hontebeyrie M, Hoebeke J, Levin MJ.

FASEB J. 2006 Jul;20(9):1396-406.

PMID:
16816115
41.

Design and activity of cationic fullerene derivatives as inhibitors of acetylcholinesterase.

Pastorin G, Marchesan S, Hoebeke J, Da Ros T, Ehret-Sabatier L, Briand JP, Prato M, Bianco A.

Org Biomol Chem. 2006 Jul 7;4(13):2556-62. Epub 2006 May 25.

PMID:
16791318
42.

IgGs and Mabs against the beta2-adrenoreceptor block A-V conduction in mouse hearts: A possible role in the pathogenesis of ventricular arrhythmias.

Escobar AL, Fernández-Gómez R, Peter JC, Mobini R, Hoebeke J, Mijares A.

J Mol Cell Cardiol. 2006 Jun;40(6):829-37. Epub 2006 May 11.

PMID:
16697002
43.

Solid-phase synthesis of CD40L mimetics.

Bianco A, Fournel S, Wieckowski S, Hoebeke J, Guichard G.

Org Biomol Chem. 2006 Apr 21;4(8):1461-3. Epub 2006 Mar 10.

PMID:
16604209
44.

Cervical cancer and HPV.

Hassen E, Briand JP, Kacem R, Chaieb A, Khairi H, Zakhama A, Remadi S, Hoebeke J, Chouchane L.

Tunis Med. 2005 Dec;83 Suppl 12:61. No abstract available.

PMID:
16430069
45.

C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L.

Fournel S, Wieckowski S, Sun W, Trouche N, Dumortier H, Bianco A, Chaloin O, Habib M, Peter JC, Schneider P, Vray B, Toes RE, Offringa R, Melief CJ, Hoebeke J, Guichard G.

Nat Chem Biol. 2005 Dec;1(7):377-82.

PMID:
16370373
46.

52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block.

Fritsch C, Hoebeke J, Dali H, Ricchiuti V, Isenberg DA, Meyer O, Muller S.

Arthritis Res Ther. 2006;8(1):R4.

47.

Carbon nanotubes: on the road to deliver.

Bianco A, Hoebeke J, Kostarelos K, Prato M, Partidos CD.

Curr Drug Deliv. 2005 Jul;2(3):253-9.

PMID:
16305427
48.

Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analog.

Monneaux F, Hoebeke J, Sordet C, Nonn C, Briand JP, Maillère B, Sibillia J, Muller S.

J Immunol. 2005 Nov 1;175(9):5839-47.

49.

Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicity.

Acres B, Gantzer M, Remy C, Futin N, Accart N, Chaloin O, Hoebeke J, Balloul JM, Paul S.

Cancer Res. 2005 Oct 15;65(20):9536-46.

50.

Supplemental Content

Loading ...
Support Center